Aberdeen Group plc Boosts Stake in Sarepta Therapeutics, Inc. $SRPT
MarketBeat
Aberdeen Group plc increased its position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 91.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,242,404 shares of the biotechnology c
NASDAQ:SRPT